Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1552 of 6351
-
New antibody BT02 takes on Hard-to-Treat blood cancers
Disease control Not yet recruitingThe goal of this clinical trial is to learn about the safety, tolerability and preliminary effectiveness of a treatment for patients with relapsed or refractory hematologic malignancies, regardless of gender, aged between 18(inclusive) and 70 years . Participants will receive th…
Phase 1/2 • Sponsor: Biotroy Therapeutics • Aim: Disease control
Last updated Jun 26, 2026 17:49 UTC
-
Papaya leaf extract tested as dengue treatment for kids
Disease control By invitation onlyThe goal of this clinical trial is to evaluate whether Carica papaya leaf extract (CPLE) can improve platelet counts in children aged 2 to 12 years diagnosed with dengue fever and thrombocytopenia. The main questions it aims to answer are: Does Carica papaya leaf extract signifi…
Phase 2 • Sponsor: Ziauddin Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:24 UTC
-
New hope for advanced breast cancer: drug combo trial launches
Disease control Not yet recruitingSoGreat is an open-label, single-arm, modular, two-stage, Phase Ib/II study. SoGreat (Part 1) is an open-label, modular, Phase Ib study.
Phase 1 • Sponsor: Hunan Cancer Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:41 UTC
-
Handheld scanners and glucose monitors aim to catch diseases early
Diagnosis By invitation onlyThis study evaluates the effectiveness of Truway Health-sourced portable diagnostic devices, including ultrasound and blood glucose monitors, in early detection of chronic conditions in outpatient primary care settings. Conducted as a prospective interventional trial, 200 partici…
Early phase 1 • Sponsor: Truway Health, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC
-
Simple urine test could spot pneumonia in kids without needles
Diagnosis Not yet recruitingBackground:Pneumonia caused by the bacteria Streptococcus pneumoniae is a leading cause of death among children under five years of age, especially in sub-Saharan Africa. Accurate diagnosis remains challenging due to the need for invasive procedures to obtain samples for culture-…
Sponsor: Liverpool School of Tropical Medicine • Aim: Diagnosis
Last updated Jun 26, 2026 18:04 UTC
-
Home videos could revolutionize early cerebral palsy detection in preemies
Diagnosis Not yet recruitingThis study aims to evaluate the validity of family-led recordings for General Movements Assessment (GMA) compared to provider-led recordings in neonates born \<29 weeks.
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
Can enzyme pills help pancreatitis patients regain lost weight?
Disease control Not yet recruitingIn this multicenter, double blinded, placebo-controlled, 1:1 parallel group RCT, we propose to evaluate the impact of pancreatic exocrine replacement therapy on patients with acute necrotizing pancreatitis (ANP). We will include patients of 18-60yrs age and both genders with \>50…
Phase 3 • Sponsor: Asian Institute of Gastroenterology, India • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New radiation regimen cuts treatment time for early glottic cancer
Disease control Not yet recruitingEarly-stage glottic carcinoma (T1-T2N0M0) is typically managed with either transoral laser microsurgery or definitive radiotherapy, both providing excellent local control rates and voice preservation outcomes. Radiotherapy remains a widely adopted non-invasive option, particularl…
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New antibody treatment could tame rare brain disease Flare-Ups
Disease control Not yet recruitingThis study aims to evaluate the efficacy and safety of different monoclonal antibody in the acute phase of neuromyelitis optica spectrum disorder (MAAP-NMO). It will also examine immune-related biomarkers and their relationship with treatment response to provide evidence for opti…
Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 26, 2026 19:21 UTC
-
New breathing method may protect preemie lungs
Disease control Recruiting nowBronchopulmonary dysplasia (BPD) is a complex disorder and remains the most common complication in very preterm infants. Its incidence is increased with gestational age from 95.5% among infants born at 22 weeks' gestation to 22.2% among those born at 29 weeks' gestation. BPD is a…
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New pill RAP-103 aims to clear psoriasis in 8 weeks
Disease control Recruiting nowRandomized, controlled trial, Proof of Concept, Phase 2 aimed to evaluate the effect of CBP-0276 in dose of 200mg twice dose a day, or placebo administrated for 36 weeks to improve Psoriasis Area and Severity Index (PASI)75 or static Physician's Global Assessment (sPGA) score of …
Phase 2 • Sponsor: Clarent Biopharma, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Triple-Drug cocktail aims to tackle rare cancer
Disease control Not yet recruitingThis study will evaluate the efficacy, safety and tolerability of Surufatinib + Temozolomide + Sintilimab in subjects. A treatment cycle of 21 days until disease progression, death, toxicity intolerance or withdrawal of informed consent, with a maximum treatment period of 24 mont…
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 26, 2026 13:43 UTC
-
Which drug first? new study aims to optimize breast cancer treatment sequence
Disease control Not yet recruitingThe combination of cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) and endocrine therapy is the standard first-line treatment for advanced HR+ (hormone receptor-positive)/HER2- (human epidermal growth factor receptor 2-negative) breast cancer. However, the optimal treatment stra…
Phase 4 • Sponsor: Yan Xue • Aim: Disease control
Last updated Jun 26, 2026 14:40 UTC
-
Single gel application may speed healing of diabetic foot wounds
Disease control Not yet recruitingThis multicenter, randomized controlled trial will evaluate the effectiveness and safety of DEBRICHEM®, a topical desiccant gel, when added to standard care for chronic diabetic foot wounds. Chronic diabetic foot ulcers affect up to 25% of people with diabetes and are associated …
Sponsor: DEBx Medical B.V. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Urine test could personalize TB treatment and save lives
Disease control Recruiting nowIndividual pharmacokinetic variability is an important driver of tuberculosis (TB) treatment failure particularly among undernourished populations, and that suboptimal serum drug concentrations are associated with delayed response to treatment, death, and acquired bacterial drug …
Phase 1 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a 'Baby Dose' of hormone drugs prevent breast cancer with fewer side effects?
Prevention Recruiting nowThe purpose of the study is to to compare low dose of exemestane (babyexe) versus low dose of tamoxifen (babytam) in terms of change of quality of life from baseline to 12 months.
Phase 2 • Sponsor: Andrea DeCensi • Aim: Prevention
Last updated Jun 27, 2026 07:57 UTC
-
New Artery-Clearing procedure could save legs from amputation
Disease control OngoingPeripheral artery disease (PAD) affects \>200 millionadults worldwide and is amajor cause of morbidity ranging from exertional lower extremity pain to ischemic rest pain and ulcer formation. Endovascular treatment options for PAD have increased dramatically in the past several d…
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New pill hopes to clear stubborn hand and foot blisters
Disease control Recruiting nowWhat's the problem? Palmoplantar pustulosis (PPP) is a long-term skin condition that mainly affects the palms of hands and soles of feet. It causes red, scaly skin with small, non-infectious blisters (called pustules), and often brings pain, itching, or even joint damage over tim…
Sponsor: Xijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Herbal extract shows promise in calming schizophrenia
Symptom relief CompletedThis study aims to evaluate the effectiveness of Ashwagandha (Withania somnifera) extract as an adjuvant therapy in patients with schizophrenia who are receiving risperidone. Schizophrenia is a chronic mental disorder associated with neuroinflammation and immune dysregulation, in…
Phase 2 • Sponsor: Hasanuddin University • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Virtual reality drills may train the body to stay calm under fire
Knowledge-focused CompletedThe purpose of this study is to examine whether repeated exposure to an active shooter or target practice virtual reality (VR) scenario alters physiological and psychological stress responses over time. Specifically, this study will determine whether the pattern and magnitude of …
Sponsor: Texas State University • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC